Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.73
-0.08 (-1.17%)
At close: Mar 20, 2026, 4:00 PM EDT
6.93
+0.20 (2.98%)
After-hours: Mar 20, 2026, 7:27 PM EDT

Unicycive Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--0.680.95--
Revenue Growth (YoY)
---29.02%---
Gross Profit
--0.680.95--
Selling, General & Admin
19.3812.18.556.572.91.01
Research & Development
12.1720.0112.912.446.081.02
Total Operating Expenses
31.5632.1221.45198.982.02
Operating Income
-31.56-32.12-20.77-18.05-8.98-2.02
Interest Income
0.971.260.62---
Interest Expense
-0.06-0.07-0.08-0.01-0.63-0.24
Other Non-Operating Income (Expense)
-2.77-5.8-10.3--0.41-
Total Non-Operating Income (Expense)
-1.86-4.61-9.77-0.01-1.04-0.24
Pretax Income
-33.41-36.73-30.54-18.06-10.02-2.26
Net Income
-33.47-37.82-31.41-18.06-10.02-2.26
Net Income Attributable to Preferred Dividends
-1.10.87---
Net Income to Common
-33.47-37.82-31.41-18.06-10.02-2.26
Shares Outstanding (Basic)
4,52572211
Shares Outstanding (Diluted)
4,52572211
Shares Change (YoY)
103.13%172.97%62.98%28.96%37.37%0.52%
EPS (Basic)
-3.94-5.60-12.80-12.00-8.60-2.70
EPS (Diluted)
-3.94-5.60-12.80-12.00-8.60-2.70
Free Cash Flow
-29.88-28.65-18.3-15.65-5.8-1.46
Free Cash Flow Per Share
-0.01-4.28-7.46-10.40-4.96-1.72
Gross Margin
--100.00%100.00%--
Operating Margin
---3077.63%-1898.21%--
Profit Margin
---4525.04%-1898.84%--
FCF Margin
---2710.37%-1645.95%--
EBITDA
-31-31.69-20.49-17.89-8.96-2.02
EBITDA Margin
---3035.56%-1881.28%--
EBIT
-31.56-32.12-20.77-18.05-8.98-2.02
EBIT Margin
---3077.63%-1898.21%--
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q